|
Extramural Support
|
RMS2013 [E]
|
$366,054,072
|
$6,289,358
|
N/A
|
National Cancer Institute
|
|
Leadership Component in Chemoprevention: Mouse Models of Human Cancer Consortium
|
5U01CA141535-05
|
$377,353
|
$377,353
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Defining mechanisms of cancer chemoresistance and metastasis
|
1K99CA172697-01
|
$158,535
|
$158,535
|
Acharyya, Swarnali
|
SLOAN-KETTERING INST CAN RES
|
|
Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy
|
3R01CA140368-04S1
|
$48,000
|
$48,000
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Prostate Cancer Prevention and Treatment by Silibinin
|
5R01CA102514-10
|
$303,143
|
$303,143
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Colon Cancer Chemoprevention by Flavonoid Silibinin
|
5R01CA112304-08
|
$269,324
|
$269,324
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy
|
5R01CA140368-04
|
$285,463
|
$285,463
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Resveratrol-Zinc Combination for Prostate Cancer
|
1R21CA176867-01
|
$196,403
|
$196,403
|
Ahmad, Nihal
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Chemoprevention of arsenic-induced skin cancer
|
5R01CA107431-09
|
$1,620,244
|
$1,620,244
|
AHSAN, HABIBUL
|
UNIVERSITY OF CHICAGO
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,207,080
|
$241,416
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Chemoprevention of Skin Cancer Program Project
|
3P01CA027502-30S1
|
$47,861
|
$47,861
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Chemoprevention of Skin Cancer Program Project
|
3P01CA027502-30S2
|
$51,771
|
$51,771
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-35S1
|
$75,000
|
$24,750
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Chemoprevention of Skin Cancer Program Project
|
5P01CA027502-30
|
$1,240,584
|
$1,240,584
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
The effects of endogenous and dietary estrogens on colonic stem cells
|
5R21CA164623-02
|
$175,438
|
$175,438
|
Allred, Clinton
|
TEXAS AGRILIFE RESEARCH
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144-07130
|
$1,156,216
|
$231,243
|
Alter, Blanche
|
DCEG (NCI)
|
|
Targeting both intrinsic and extrinsic apoptosis by FLLL-12 in lung cancer
|
1R03CA171663-01A1
|
$78,000
|
$78,000
|
Amin, A.R.M.
|
EMORY UNIVERSITY
|
|
Mechanism of chemopreventive synergism from the combination of EGCG and Erlotinib
|
5R03CA159369-02
|
$72,850
|
$72,850
|
Amin, A.R.M.
|
EMORY UNIVERSITY
|
|
Dietary Prevention of Cancer
|
5R01CA109269-10
|
$264,653
|
$264,653
|
ANANT, SHRIKANT
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
Targeting Sterol Gene SC4MOL and EGFR as Synergistic Anti-Cancer Strategy
|
5K22CA160725-03
|
$195,961
|
$97,981
|
Astsaturov, Igor
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Targeting Sterol Gene SC4MOL and EGFR as Synergistic Anti-Cancer Strategy
|
7K22CA160725-04
|
$195,961
|
$97,981
|
Astsaturov, Igor
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Inhibiting Multiple Molecular Targets for Preventing Non-Melanoma Skin Cancer
|
5R01CA138998-03
|
$285,749
|
$285,749
|
ATHAR, MOHAMMAD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-27
|
$1,874,946
|
$149,996
|
Atkins, James
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
MODULATION OF INTESTINAL HOMEOSTASIS AND CANCER
|
5R01CA135561-05
|
$289,457
|
$289,457
|
AUGENLICHT, LEONARD
|
MONTEFIORE MEDICAL CENTER (BRONX, NY)
|
|
Postdoctoral Training in Cancer Control Research
|
5R25CA122061-06
|
$442,044
|
$44,204
|
AVIS, NANCY
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
San Juan Minority-Based Community Clinical Oncology Program
|
2U10CA052667-23
|
$573,647
|
$45,892
|
BAEZ, LUIS
|
SAN JUAN HEALTH DEPARTMENT
|
|
Prevention of prostate cancer growth by a plant alkaloid
|
5R01CA131123-05
|
$299,402
|
$299,402
|
BANERJEE, PARTHA
|
GEORGETOWN UNIVERSITY
|
|
Colorectal Chemoprevention with Calcium and Vitamin D
|
2R01CA098286-11
|
$2,871,949
|
$2,871,949
|
Baron, John
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Aspirin/Folate Prevention of Large Bowel Polyps
|
5R01CA059005-18
|
$485,122
|
$485,122
|
Baron, John
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Dual Modality System for Imaging Colon Cancer in Mice
|
5R01CA109385-10
|
$285,247
|
$57,049
|
Barton, Jennifer
|
UNIVERSITY OF ARIZONA
|
|
Dopamine as a therapeutic agent in stomach cancer
|
1R01CA169158-01A1
|
$317,821
|
$158,911
|
Basu, Sujit
|
OHIO STATE UNIVERSITY
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-29
|
$1,065,000
|
$85,200
|
Bearden, James
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
Cancer Center Support Grant
|
3P30CA042014-24S1
|
$43,750
|
$875
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
5P30CA042014-24
|
$1,433,304
|
$28,666
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
Iowa Oncology Research Association
|
5U10CA035101-28
|
$747,553
|
$59,804
|
Behrens, Robert
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
Bioavailability and activity of dietary naringenin as a chemopreventive agent
|
5R03CA162551-02
|
$71,093
|
$71,093
|
BELURY, MARTHA
|
OHIO STATE UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA022453-31S1
|
$12,500
|
$1,250
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA022453-31S2
|
$50,000
|
$5,000
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA022453-31
|
$2,376,242
|
$237,624
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Hawaii Minority-Based Clinical Community Oncology Program
|
5U10CA063844-20
|
$736,823
|
$58,946
|
Berenberg, Jeffrey
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-28S1
|
$362,418
|
$28,993
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
5U10CA037447-29
|
$2,684,982
|
$214,799
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Research Training Program in Surgical Oncology
|
5T32CA091078-12
|
$320,646
|
$48,097
|
Bland, Kirby
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
SWOG Community Clinical Oncology Program Research Base
|
7U10CA037429-29
|
$4,229,363
|
$338,349
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
GUCY2C hormone suppression links obesity with colorectal cancer
|
1F30CA180500-01
|
$42,910
|
$14,160
|
Blomain, Erik
|
THOMAS JEFFERSON UNIVERSITY
|
|
Carcinogenic Metabolites Formed from Antiestrogen
|
5R01CA079870-14
|
$209,632
|
$104,816
|
Bolton, Judy
|
UNIVERSITY OF ILLINOIS
|
|
Metformin and breast cancer risk
|
1R03CA167589-01A1
|
$80,000
|
$80,000
|
Boudreau, DENISE
|
GROUP HEALTH COOPERATIVE
|
|
Colon Cancer Chemoprevention with Phosphodiesterase-5 Inhibitors
|
1R01CA172627-01A1
|
$309,175
|
$309,175
|
BROWNING, DARREN
|
GEORGIA REGENTS UNIVERSITY
|
|
Community Clinical Oncology Program
|
5U10CA037422-26
|
$2,811,894
|
$224,952
|
BRUNER, DEBORAH
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
SPORE in Lung Cancer
|
3P50CA058187-18S1
|
$1,233,307
|
$616,654
|
BUNN, PAUL
|
UNIVERSITY OF COLORADO DENVER
|
Total relevant funding to Chemoprevention for this search: $115,022,141
|